Novo Nordisk A/S
NOVO B
ISIN DK0062498333 / Valor 129508879
Novo Nordisk A/S
UMushroom community rating:
About company
Novo Nordisk A/S, founded in 1923 and headquartered near Copenhagen, Denmark, is a leading global healthcare company specializing in the development, manufacturing, and marketing of pharmaceutical products. The company is renowned for its extensive range of diabetes care solutions, including various insulin therapies and innovative treatments aimed at improving patient outcomes. In addition to diabetes, Novo Nordisk also focuses on other therapeutic areas such as obesity, hemophilia, and growth disorders, leveraging advanced biotechnology to address unmet medical needs. Committed to research and development, Novo Nordisk invests significantly in scientific advancements to maintain its position in the competitive biopharmaceutical industry. The company's long-standing dedication to improving health through sustainable and effective treatments underscores its role as a key player in the global healthcare market.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
122841 M
Market cap (USD)
5,407,216
Daily traded volume (Shares)
645.6 / 626.4
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Corbin Newbury
Faraz Abedi
Jules Broglin
EQUITIES OF THE SAME SECTOR
